Percutaneous coronary transluminal angioplasty is considered for payment in the treatment of acute myocardial infarction as an alternative method for patients who do not have contraindications for thrombolysis.
Coronary transluminal percutaneous angioplasty is considered for payment as the first option for patients with contraindications for thrombolysis such as cardiogenic shock, advanced age, or a previous history of coronary bypass.